SHBG, free testosterone, and type 2 diabetes risk in middle-aged African men: a longitudinal study
SHBG, free testosterone, and type 2 diabetes risk in middle-aged African men: a longitudinal study
Objectives: to investigate longitudinal changes in SHBG and free testosterone (free T) levels among Black middle-aged African men, with and without coexistent HIV, and explore associations with incident dysglycaemia and measures of glucose metabolism.
Design: this longitudinal study enrolled 407 Black South African middle-aged men, comprising primarily 322 men living without HIV (MLWOH) and 85 men living with HIV (MLWH), with normal fasting glucose at enrollment. Follow-up assessments were conducted after 3.1 ± 1.5 years.
Methods: at baseline and follow-up, SHBG, albumin, and total testosterone were measured and free T was calculated. An oral glucose tolerance test at follow-up determined dysglycaemia (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and glucose metabolism parameters including insulin sensitivity (Matsuda index), insulin resistance (homeostasis model assessment of insulin resistance), and beta(β)cell function (disposition index). The primary analysis focussed on MLWOH, with a subanalysis on MLWH to explore whether associations in MLWOH differed from MLWH.
Results: the prevalence of dysglycaemia at follow-up was 17% (n = 55) in MLWOH. Higher baseline SHBG was associated with a lower risk of incident dysglycaemia (odds ratio 0.966; 95% confidence interval 0.945-0.987) and positively associated with insulin sensitivity (β = 0.124, P < .001) and β-cell function (β = 0.194, P = .001) at follow-up. Free T did not predict dysglycaemia. In MLWH, dysglycaemia prevalence at follow-up was 12% (n = 10). Neither baseline SHBG nor free T were associated with incident dysglycaemia and glucose metabolism parameters in MLWH.
Conclusion: SHBG levels predict the development of dysglycaemia in middle-aged African men but do not exhibit the same predictive value in MLWH.
Africa, dysglycaemia, free testosterone, sex hormine-binding globulin, type 2 diabetes, sex hormone-binding globulin
Seipone, Ikanyeng D.
a21647f2-f323-4ae5-85f9-102cec5421cd
Mendham, Amy E.
b74f6cc8-c7e1-47d9-9361-18ee63667e60
Storbeck, Karl-Heinz
23505057-d47e-4e98-92d3-e0496ceb74f8
Oestlund, Imken
69aacba8-6ae4-45ab-bb0f-88698ab5101d
Kufe, Clement N.
3b839b26-ac35-463f-9e39-ef5c4b083f05
Chikowore, Tinashe
b53b1cb9-8363-4e2c-9d62-dc3a8627a7b5
Masemola, Maphoko
ac19dd6b-c441-4ed9-9093-2f7816deb97a
Crowther, Nigel J.
ca4aa5ba-4f92-4c4d-9736-1dcf303dee40
Kengne, Andre Pascal
1cbc23a3-c104-4f2c-b804-323ce91b856a
Norris, Shane
1d346f1b-6d5f-4bca-ac87-7589851b75a4
Olsson, Tommy
b471ee17-d479-4f76-bd3e-ee88a308de10
Brown, Todd
9057fa4b-268c-4ec7-ad4f-e6ba7424dfd0
Micklesfield, Lisa K.
e73dd95b-ce79-4dc4-b0be-a8935eb069c8
Goedecke, Julia H.
27db2aa1-04c2-44e8-9c0e-e9bbe98f2e25
25 July 2024
Seipone, Ikanyeng D.
a21647f2-f323-4ae5-85f9-102cec5421cd
Mendham, Amy E.
b74f6cc8-c7e1-47d9-9361-18ee63667e60
Storbeck, Karl-Heinz
23505057-d47e-4e98-92d3-e0496ceb74f8
Oestlund, Imken
69aacba8-6ae4-45ab-bb0f-88698ab5101d
Kufe, Clement N.
3b839b26-ac35-463f-9e39-ef5c4b083f05
Chikowore, Tinashe
b53b1cb9-8363-4e2c-9d62-dc3a8627a7b5
Masemola, Maphoko
ac19dd6b-c441-4ed9-9093-2f7816deb97a
Crowther, Nigel J.
ca4aa5ba-4f92-4c4d-9736-1dcf303dee40
Kengne, Andre Pascal
1cbc23a3-c104-4f2c-b804-323ce91b856a
Norris, Shane
1d346f1b-6d5f-4bca-ac87-7589851b75a4
Olsson, Tommy
b471ee17-d479-4f76-bd3e-ee88a308de10
Brown, Todd
9057fa4b-268c-4ec7-ad4f-e6ba7424dfd0
Micklesfield, Lisa K.
e73dd95b-ce79-4dc4-b0be-a8935eb069c8
Goedecke, Julia H.
27db2aa1-04c2-44e8-9c0e-e9bbe98f2e25
Seipone, Ikanyeng D., Mendham, Amy E., Storbeck, Karl-Heinz, Oestlund, Imken, Kufe, Clement N., Chikowore, Tinashe, Masemola, Maphoko, Crowther, Nigel J., Kengne, Andre Pascal, Norris, Shane, Olsson, Tommy, Brown, Todd, Micklesfield, Lisa K. and Goedecke, Julia H.
(2024)
SHBG, free testosterone, and type 2 diabetes risk in middle-aged African men: a longitudinal study.
Journal of the Endocrine Society, 8 (8), [bvae129].
(doi:10.1210/jendso/bvae129).
Abstract
Objectives: to investigate longitudinal changes in SHBG and free testosterone (free T) levels among Black middle-aged African men, with and without coexistent HIV, and explore associations with incident dysglycaemia and measures of glucose metabolism.
Design: this longitudinal study enrolled 407 Black South African middle-aged men, comprising primarily 322 men living without HIV (MLWOH) and 85 men living with HIV (MLWH), with normal fasting glucose at enrollment. Follow-up assessments were conducted after 3.1 ± 1.5 years.
Methods: at baseline and follow-up, SHBG, albumin, and total testosterone were measured and free T was calculated. An oral glucose tolerance test at follow-up determined dysglycaemia (impaired fasting glucose, impaired glucose tolerance, type 2 diabetes) and glucose metabolism parameters including insulin sensitivity (Matsuda index), insulin resistance (homeostasis model assessment of insulin resistance), and beta(β)cell function (disposition index). The primary analysis focussed on MLWOH, with a subanalysis on MLWH to explore whether associations in MLWOH differed from MLWH.
Results: the prevalence of dysglycaemia at follow-up was 17% (n = 55) in MLWOH. Higher baseline SHBG was associated with a lower risk of incident dysglycaemia (odds ratio 0.966; 95% confidence interval 0.945-0.987) and positively associated with insulin sensitivity (β = 0.124, P < .001) and β-cell function (β = 0.194, P = .001) at follow-up. Free T did not predict dysglycaemia. In MLWH, dysglycaemia prevalence at follow-up was 12% (n = 10). Neither baseline SHBG nor free T were associated with incident dysglycaemia and glucose metabolism parameters in MLWH.
Conclusion: SHBG levels predict the development of dysglycaemia in middle-aged African men but do not exhibit the same predictive value in MLWH.
Text
bvae129
- Version of Record
More information
e-pub ahead of print date: 19 July 2024
Published date: 25 July 2024
Keywords:
Africa, dysglycaemia, free testosterone, sex hormine-binding globulin, type 2 diabetes, sex hormone-binding globulin
Identifiers
Local EPrints ID: 497011
URI: http://eprints.soton.ac.uk/id/eprint/497011
ISSN: 2472-1972
PURE UUID: 3bd44acc-8fa4-4c18-be36-679e76bd10b9
Catalogue record
Date deposited: 09 Jan 2025 18:03
Last modified: 10 Jan 2025 03:05
Export record
Altmetrics
Contributors
Author:
Ikanyeng D. Seipone
Author:
Amy E. Mendham
Author:
Karl-Heinz Storbeck
Author:
Imken Oestlund
Author:
Clement N. Kufe
Author:
Tinashe Chikowore
Author:
Maphoko Masemola
Author:
Nigel J. Crowther
Author:
Andre Pascal Kengne
Author:
Tommy Olsson
Author:
Todd Brown
Author:
Lisa K. Micklesfield
Author:
Julia H. Goedecke
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
